• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性膝骨关节炎患者疼痛缓解不充分。

Inadequate pain relief among patients with primary knee osteoarthritis.

作者信息

Laires Pedro A, Laíns Jorge, Miranda Luís C, Cernadas Rui, Rajagopalan Srini, Taylor Stephanie D, Silva José C

机构信息

Merck, Sharp & Dohme, Oeiras, Portugal.

Centro de Medicina de Reabilitação da Região Centro, Tocha, Portugal.

出版信息

Rev Bras Reumatol Engl Ed. 2017 May-Jun;57(3):229-237. doi: 10.1016/j.rbre.2016.11.005. Epub 2016 Dec 5.

DOI:10.1016/j.rbre.2016.11.005
PMID:28535895
Abstract

BACKGROUND

Despite the widespread treatments for osteoarthritis (OA), data on treatment patterns, adequacy of pain relief, and quality of life are limited. The prospective multinational Survey of Osteoarthritis Real World Therapies (SORT) was designed to investigate these aspects.

OBJECTIVES

To analyze the characteristics and the patient reported outcomes of the Portuguese dataset of SORT at the start of observation.

METHODS

Patients ≥50 years with primary knee OA who were receiving oral or topical analgesics were eligible. Patients were enrolled from seven healthcare centers in Portugal between January and December 2011. Pain and function were evaluated using the Brief Pain Inventory (BPI) and WOMAC. Quality of life was assessed using the 12-Item Short Form Health Survey (SF-12). Inadequate pain relief (IPR) was defined as a score >4/10 on item 5 of the BPI.

RESULTS

Overall, 197 patients were analyzed. The median age was 67.0 years and 78.2% were female. Mean duration of knee OA was 6.2 years. IPR was reported by 51.3% of patients. Female gender (adjusted odds ratio - OR 2.15 [95%CI 1.1, 4.5]), diabetes (OR 3.1 [95%CI 1.3, 7.7]) and depression (OR 2.24 [95%CI 1.2, 4.3]) were associated with higher risk of IPR. Patients with IPR reported worst outcomes in all dimensions of WOMAC (p<0.001) and in all eight domains and summary components of SF-12 (p<0.001).

CONCLUSIONS

Our findings indicate that improvements are needed in the management of pain in knee OA in order to achieve better outcomes in terms of pain relief, function and quality of life.

摘要

背景

尽管骨关节炎(OA)有广泛的治疗方法,但关于治疗模式、疼痛缓解的充分性和生活质量的数据有限。前瞻性跨国骨关节炎真实世界治疗调查(SORT)旨在调查这些方面。

目的

分析SORT葡萄牙数据集在观察开始时的特征和患者报告的结局。

方法

年龄≥50岁、患有原发性膝骨关节炎且正在接受口服或外用镇痛药治疗的患者符合条件。2011年1月至12月期间,从葡萄牙的七个医疗中心招募患者。使用简明疼痛量表(BPI)和WOMAC评估疼痛和功能。使用12项简短健康调查(SF-12)评估生活质量。疼痛缓解不足(IPR)定义为BPI第5项得分>4/10。

结果

总体而言,分析了197例患者。中位年龄为67.0岁,78.2%为女性。膝骨关节炎的平均病程为6.2年。51.3%的患者报告有疼痛缓解不足。女性(调整后的优势比-OR 2.15 [95%CI 1.1, 4.5])、糖尿病(OR 3.1 [95%CI 1.3, 7.7])和抑郁症(OR 2.24 [95%CI 1.2, 4.3])与疼痛缓解不足的风险较高相关。疼痛缓解不足的患者在WOMAC的所有维度(p<0.001)以及SF-12的所有八个领域和总结成分中报告的结局最差(p<0.001)。

结论

我们的研究结果表明,为了在疼痛缓解、功能和生活质量方面取得更好的结局,膝骨关节炎的疼痛管理需要改进。

相似文献

1
Inadequate pain relief among patients with primary knee osteoarthritis.原发性膝骨关节炎患者疼痛缓解不充分。
Rev Bras Reumatol Engl Ed. 2017 May-Jun;57(3):229-237. doi: 10.1016/j.rbre.2016.11.005. Epub 2016 Dec 5.
2
Inadequate pain relief among patients with primary knee osteoarthritis.原发性膝骨关节炎患者疼痛缓解不充分。
Rev Bras Reumatol. 2016 Oct 28. doi: 10.1016/j.rbr.2016.09.003.
3
Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies.膝关节骨关节炎患者疼痛缓解不足和功能丧失较大:来自骨关节炎真实世界治疗的前瞻性多国家纵向研究的证据。
Rheumatology (Oxford). 2015 Feb;54(2):270-7. doi: 10.1093/rheumatology/keu332. Epub 2014 Aug 23.
4
Results from a cross-sectional, observational study to assess inadequate pain relief in patients with knee and/or hip osteoarthritis in Mexico.评估墨西哥膝关节和/或髋关节骨关节炎患者疼痛缓解不足的横断面观察性研究结果。
Reumatol Clin (Engl Ed). 2021 Aug-Sep;17(7):397-403. doi: 10.1016/j.reumae.2019.11.008.
5
Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan.度洛西汀在既往使用非甾体抗炎药(NSAID)的患者中治疗慢性膝骨关节炎疼痛的疗效:一项在日本进行的随机、安慰剂对照3期研究的事后亚组分析。
J Orthop Sci. 2018 Nov;23(6):1019-1026. doi: 10.1016/j.jos.2018.07.008. Epub 2018 Aug 17.
6
Sensitivity to Change of a Computer Adaptive Testing Instrument for Outcome Measurement After Hip and Knee Arthroplasty and Periacetabular Osteotomy.髋膝关节置换术和髋臼周围截骨术后用于结果测量的计算机自适应测试工具对变化的敏感性。
J Orthop Sports Phys Ther. 2016 Sep;46(9):756-67. doi: 10.2519/jospt.2016.6442. Epub 2016 Aug 5.
7
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.一项为期2周的多中心、随机、双盲、安慰剂对照、剂量范围研究的III期试验,比较了羟考酮缓释剂与安慰剂对患有髋部或膝部骨关节炎相关疼痛的成年人的疗效。
Clin Ther. 2006 Mar;28(3):352-64. doi: 10.1016/j.clinthera.2006.03.008.
8
Quality of life and self-reported disability in patients with knee osteoarthritis.膝关节骨关节炎患者的生活质量和自我报告的残疾情况。
Mod Rheumatol. 2014 Jan;24(1):166-71. doi: 10.3109/14397595.2013.854046.
9
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.5%利多卡因贴剂与塞来昔布治疗骨关节炎相关性膝关节疼痛的有效性和耐受性比较:一项针对成年人的12周前瞻性、随机、活性对照、开放标签、平行组试验的事后分析
Clin Ther. 2008 Dec;30(12):2366-77. doi: 10.1016/j.clinthera.2008.12.015.
10
Efficacy and short-term safety of topical Dwarf Elder (Sambucus ebulus L.) versus diclofenac for knee osteoarthritis: A randomized, double-blind, active-controlled trial.外用矮接骨木(接骨木)与双氯芬酸治疗膝骨关节炎的疗效和短期安全性:一项随机、双盲、活性对照试验。
J Ethnopharmacol. 2016 Jul 21;188:80-6. doi: 10.1016/j.jep.2016.04.035. Epub 2016 Apr 26.

引用本文的文献

1
The spectrum of anguish from osteoarthritis sparks physiological or psychological needs in the young-old and the old-old determined by gender.骨关节炎带来的痛苦范围引发了年轻老年人和老年老年人因性别而异的生理或心理需求。
Medicine (Baltimore). 2025 Apr 25;104(17):e42239. doi: 10.1097/MD.0000000000042239.
2
A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.一项评估法西珠单抗用于膝或髋骨关节炎所致疼痛患者的长期安全性和疗效的III期研究。
Osteoarthr Cartil Open. 2024 Oct 22;6(4):100533. doi: 10.1016/j.ocarto.2024.100533. eCollection 2024 Dec.
3
Burden of Disease and Cost of Illness of Overweight and Obesity in Portugal.
葡萄牙超重和肥胖的疾病负担及疾病成本
Obes Facts. 2025;18(2):107-120. doi: 10.1159/000541781. Epub 2024 Nov 5.
4
Influence of Risk Factors on the Well-Being of Elderly Women with Knee Osteoarthritis.危险因素对老年膝骨关节炎女性幸福感的影响。
Medicina (Kaunas). 2023 Jul 29;59(8):1396. doi: 10.3390/medicina59081396.
5
Prevalence of and factors associated with unmanageable pain levels in people with knee or hip osteoarthritis: a cross-sectional population-based study.膝关节或髋关节骨关节炎患者中疼痛程度不可管理的流行状况及相关因素:一项基于人群的横断面研究。
BMC Musculoskelet Disord. 2023 Jan 23;24(1):60. doi: 10.1186/s12891-022-06110-1.
6
Self-Photopolymerizable Hydrogel-Ceramic Composites with Scavenger Properties.具有清除剂特性的自光聚合水凝胶-陶瓷复合材料
Polymers (Basel). 2022 Mar 21;14(6):1261. doi: 10.3390/polym14061261.
7
The effects of resistance training with blood flow restriction on muscle strength, muscle hypertrophy and functionality in patients with osteoarthritis and rheumatoid arthritis: A systematic review with meta-analysis.抗阻训练联合血流限制对骨关节炎和类风湿关节炎患者肌肉力量、肌肉肥大和功能的影响:系统评价和荟萃分析。
PLoS One. 2021 Nov 10;16(11):e0259574. doi: 10.1371/journal.pone.0259574. eCollection 2021.
8
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain.一项多中心、随机、双盲、安慰剂对照试验,评估一种新型低剂量姜黄提取物制剂在患有慢性膝关节疼痛的健康成年人中的疗效和安全性。
Clin Pharmacol. 2021 May 21;13:91-100. doi: 10.2147/CPAA.S307464. eCollection 2021.
9
The association of pain interference and opioid use with healthcare utilization and costs, and wage loss among adults with osteoarthritis in the United States.在美国,成年人骨关节炎患者的疼痛干扰、阿片类药物使用与医疗保健利用和成本、工资损失之间的关系。
J Med Econ. 2019 Nov;22(11):1192-1201. doi: 10.1080/13696998.2019.1658590. Epub 2019 Sep 9.
10
Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3.亚甲蓝通过上调lncRNA MEG3减轻骨关节炎的发展。
Exp Ther Med. 2018 Apr;15(4):3856-3864. doi: 10.3892/etm.2018.5918. Epub 2018 Mar 2.